Marcial: The Formula for a Pfizer Recovery
A glance at the stock chart of Pfizer (PFE), the world's largest pharmaceutical company, could make you sick—if you own the stock. It is now trading at its 52-week low of $17.96 a share, down from $27 a year ago and way down from $50, where it was in 2000. After the vertigo, nausea, and other side effects of experiencing such a precipitous plunge, you might even think about calling your broker, if you haven't already, to sell the stock.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
- Tesla Unveils ‘World’s Fastest Production Car’ and Electric Big Rig
- Norway Idea to Exit Oil Stocks Is ‘Shot Heard Around the World’
- Getting a Dog May Save Your Life, Especially If You’re Single
- World’s Biggest Wealth Fund Wants Out of Oil and Gas
- The Questionable Math Behind Manafort’s Extravagant Home Renovations